The Liu Lab develops next-generation genome editing tools to treat genetic diseases.
Our goal is to create safe, effective, and clinically translatable therapies.Our research integrates novel editing strategies with AAV and lipid nanoparticle delivery, targeting disorders of the liver, nervous system, and muscle.